Dergiler / Bozok Tıp Dergisi / 2019 / Cilt: 9 - Sayı: 2

MESANE YAN DUVAR TÜMÖRLERİNİN TRANSÜRETRAL REZEKSİYONU SIRASINDA OBTURATOR SİNİR BLOĞUNUN; TÜMÖR ÖRNEKLERİNDE DETRUSOR KASI VARLIĞI VE HASTALIĞIN NÜKSETMESİ ÜZERİNE ETKİSİ Effect of Obturator Nerve Block During Transurethral Resection of Bladder Lateral Wall Tumors on Presence of Detrusor Muscle in

Sayfa
95–101
Yayın Tarihi
2019-06-28
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗

Özet

ÖZET

🔖

Bu Makaleye Atıf Yap

DADALI, M., ERŞEKERCİ, E. (2019). MESANE YAN DUVAR TÜMÖRLERİNİN TRANSÜRETRAL REZEKSİYONU SIRASINDA OBTURATOR SİNİR BLOĞUNUN; TÜMÖR ÖRNEKLERİNDE DETRUSOR KASI VARLIĞI VE HASTALIĞIN NÜKSETMESİ ÜZERİNE ETKİSİ Effect of Obturator Nerve Block During Transurethral Resection of Bladder Lateral Wall Tumors on Presence of Detrusor Muscle in. Bozok Tıp Dergisi, Cilt: 9 - Sayı: 2, 95–101. https://ajindex.com/articles/479189

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Siegel RL, Miller KD, Jemal A. Cancerstatistics 2017. CA Cancer J Clin 2017;67(1):7–30. 2.Mydlo JH, Weinstein R, Shah S, Solliday M, Macchia RJ. Long term consequences from bladder perforation and/or violationin the presence of transitional cell carcinoma: results of a small series and a review of the literature. J Urol. 1999;161:1128-32. 3.Jancke G, Rosell J, Jahnson S. Residual tumor in the marginal resection after a complete transurethral resection is associated with local recurrence in Ta/T1 urinary bladder cancer. Scand J Urol Nephrol. 2012;46:343-7. 4.Mariappan P, Zachou A, Grigor KM. Detrusormuscle in the first, apparently complete transurethral resection of bladder tumor specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol. 2010;57:843-9. 5.Divrik RT, Yildirim U, Zorlu F, Ozen H. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomised clinicaltrial. J Urol. 2006;175:1641-4. 6.Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J, et al. EAU guidelines on non-muscle invasive urothelial carcinoma of the bladder the 2011 update. EurUrol. 2011;59:997-1008. 7.Brausi M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W, Witjes JA, et al. Variability in therecurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol. 2002;41:523-31. 8.Maruniak NA, Takezawa K, Murphy WM. Accurate pathological staging of urothelial neoplasms requires beter cystoscopic sampling. J Urol. 2002;167:2404-7. 9.Capogrosso P, Capitanio U, Ventimiglia E, Boeri L, Briganti A, Colombo R, et al. Detrusor muscle in TUR derived bladder tumor specimens: can we actually improve the surgical quality? J Endourol. 2016;4:400-5. 10.Creevy CD. Preventing stimulation of the obturator nevre during transurethral resection. J Urol.1969;101:368.